Tag:
darexaban
Latest Headlines
Latest Headlines
Astellas shelves PhIII clot drug as rival blockbusters crowd market
Just weeks after unveiling some troubling mid-stage data on the risk of bleeding among patients with acute coronary syndrome, Astellas has decided to kill off its late-stage program for the
Bleeding risk spikes for Astellas's PhII anticoagulant
Just days after Pfizer ( $PFE ) and Bristol-Myers Squibb ( $BMY ) offered up stellar safety and efficacy data on their anti-clotting therapy Eliquis, researchers revealed that Astellas's oral
